EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions

Liyun Lu, Yinhua Deng, Junnan Li, Xing Feng iD, Hui Zou

International Journal of Molecular Sciences · 18.06.2025 · 26 (12) · 5853

DOI: 10.3390/ijms26125853 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.06.2025. Verfasst von Liyun Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Health Science Center, Hunan …. Hauptthemen laut MEDLINE: Apigenin, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Platform of Health Science Center, Hunan Normal University (Cancer Targeted Intervention Research Center), Hunan Provincial Natural Science Foundation of China, Hunan Provincial Health Commission Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a leading global health challenge, necessitating the exploration of novel therapeutic strategies. Vitexin (apigenin-8-C-β-D-glucopyranoside), a natural flavonoid glycoside with a molecular weight of 432.38 g/mol, is derived from plants such as mung bean, beetroot, and hawthorn. This compound features a distinctive C-glycosidic bond at the 8-position of its apigenin backbone, contributing to its enhanced metabolic stability compared to O-glycosidic flavonoids. Preclinical studies demonstrate that vitexin modulates critical cellular processes such as cell cycle progression, apoptosis, autophagy, metastasis, angiogenesis, epigenetic modifications, and tumor glycolysis inhibition. It exerts its effects by targeting key signaling pathways, including phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and signal transducer and activator of transcription 3 (STAT3), and shows potential for combination therapies to enhance efficacy and overcome resistance. Advances in nanotechnology further enhance its bioavailability and delivery potential. This review comprehensively examines the current evidence on vitexin’s anticancer mechanisms, highlighting its multi-target therapeutic potential and future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApigeninNeoplasmsAntineoplastic AgentsHumansSignal TransductionAnimalsApoptosisAutophagy

Stichwörter der Autor:innen

anti-cancermolecular mechanismvitexin

Substanzen

ApigeninvitexinAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Health Science Center, Hunan Normal University, Changsha 410013, China.
  • Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Hunan Normal University, Changsha 410013, China.
  • Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Manufacture-Based Learning and Research Demonstration Center for Human Reproductive Health New Technology of Hunan Normal University, Hunan Normal…

ORCID-Profile: Xing Feng

Förderung

  • Research Platform of Health Science Center, Hunan Normal University (Cancer Targeted Intervention Research Center)
  • Hunan Provincial Natural Science Foundation of China
  • Hunan Provincial Health Commission Program
  • Hunan Provincial Key Laboratory of Anti-Resistance Microbial Drugs, the Third hospital of Changsha
  • Undergraduate Innovative Experiment Program of Hunan Province

Zitieren

APA

Lu, L., Deng, Y., Li, J., Feng, X., & Zou, H. (2025). Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions. International Journal of Molecular Sciences, 26(12), 5853. https://doi.org/10.3390/ijms26125853

Vancouver

Lu L, Deng Y, Li J, Feng X, Zou H. Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions. International Journal of Molecular Sciences. 2025;26(12):5853. doi:10.3390/ijms26125853

BibTeX
@article{Lu2025,
  author = {Lu, Liyun and Deng, Yinhua and Li, Junnan and Feng, Xing and Zou, Hui},
  title = {Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {12},
  pages = {5853},
  doi = {10.3390/ijms26125853}
}
Kostenlos starten →